Skip to main content
Caplight Logo









Juvisé Pharmaceuticals

Juvisé Pharmaceuticals

Private
VilleurbanneHealthcare & Life Scienceshttps://juvisepharmaceuticals.com/

Last Round

Debt

Feb 9, 2026

Total Funding Raised

$889M

Company Overview

Juvisé Pharmaceuticals is a specialty pharmaceutical company that acquires and markets essential medicines in therapeutic areas including oncology, cardiology, gastroenterology, and neuroscience.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Pharma Supply Chain

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

specialty pharmaceuticalspharmaceutical asset acquisitionlegacy drug commercializationpharma divestmentoncology medicinedrug lifecycle managementpharmaceutical supply chainpharmacovigilanceregulatory complianceasset-light pharmabranded genericspharma roll-upcontract manufacturingCMO

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Juvisé Pharmaceuticals Comparables

Compare Juvisé Pharmaceuticals with similar companies based on industry and business-model similarity.

Juvisé Pharmaceuticals comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Pharmanovia
86%
CHEPLAPHARM Arzneimittel GmbH
85%
Essential Pharma
84%

Juvisé Pharmaceuticals Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
DebtFeb 9, 2026
Private EquityMar 26, 2024
DebtFeb 4, 2020

Key People

Founding team and executive leadership

Emilie Gounon

COO - Directeur général

Executive Team

Juvisé Pharmaceuticals Investors

Notable investors and investment history

Juvisé Pharmaceuticals investors
InvestorRounds
Hayfin Capital ManagementDebt
Pemberton Asset ManagementPrivate Equity
BpifrancePrivate Equity

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 11, 2025

    Monthly visitors increased 53% MoM.

  • May 11, 2025

    Grew 23% QoQ, from 71 to 87 employees.

Juvisé Pharmaceuticals Filings

Explore SEC and related filing metadata, where available.

Juvisé Pharmaceuticals filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Juvisé Pharmaceuticals's valuation, stock price, and market status.

Is Juvisé Pharmaceuticals a public or private company?

Juvisé Pharmaceuticals is a private company.

What is the current stock price of Juvisé Pharmaceuticals?

Juvisé Pharmaceuticals is a private company with no public stock price. No recent secondary market data is available.

How much is Juvisé Pharmaceuticals worth (valuation)?

Valuation information for Juvisé Pharmaceuticals is not publicly available.

Can I buy Juvisé Pharmaceuticals stock?

Juvisé Pharmaceuticals shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Juvisé Pharmaceuticals's last funding round?

Juvisé Pharmaceuticals's most recent funding round was Debt on February 9, 2026.

Who are the main investors in Juvisé Pharmaceuticals?

Key investors in Juvisé Pharmaceuticals include Hayfin Capital Management.

Will Juvisé Pharmaceuticals IPO soon?

No public IPO plans have been announced for Juvisé Pharmaceuticals.

How can I track Juvisé Pharmaceuticals secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Juvisé Pharmaceuticals's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersVilleurbanne
Employee Range111
Year Founded2008
Last FundingFeb 9, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?